Alcuris Pharmaceuticals Private Limited
About Alcuris Pharmaceuticals Private Limited
Data last updated:
Alcuris Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85191UP2015PTC071548. Its GSTIN is 09AANCA5528K1Z7 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandeep Sahai (Managing Director) and Surpreet Sahai.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 647B/I – 172A Jankipuram Garden, Lucknow, Uttar Pradesh, India – 226021.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.67 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net loss of ₹2.3 Lakh (net margin -9%) and EBITDA of ₹60,459 (EBITDA margin 2.4%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years and 5% over five years.
Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Alcuris Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address647B/I – 172A Jankipuram Garden, Lucknow, Uttar Pradesh, India – 226021
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Alcuris Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alcuris Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Alcuris Pharmaceuticals Private Limited, buy the company report.
Financials of Alcuris Pharmaceuticals Private Limited
FY 2024 filings availableAlcuris Pharmaceuticals Private Limited reported revenue of ₹25.67 Lakh (down 14% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 14% fall in the latest year. EBITDA fell 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹60,459 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | -9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alcuris Pharmaceuticals Private Limited, buy the company report.
Board of directors of Alcuris Pharmaceuticals Private Limited
Alcuris Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surpreet Sahai | Director | 12 Feb 2016 | 10 Years 8 Months | Current |
| Sandeep Sahai | Managing Director | 12 Feb 2016 | 10 Years 8 Months | Current |
Shareholding
The shareholding of Alcuris Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Alcuris Pharmaceuticals Private Limited, buy the company report.
Legal cases
Alcuris Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Ajanta Pharma Limited | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Ajanta Pharma Limited | Disposed |
To see the full case history of Alcuris Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alcuris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alcuris Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AANCA5528K1Z7 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Alcuris Pharmaceuticals Private Limited, buy the company report.
Recent activity
Alcuris Pharmaceuticals Private Limited has 7 board changes on record since 2016: 2 appointments and 5 cessations. The latest: Simran Singh ceased to be Director on 28 Feb 2020.
Frequently asked questions
Alcuris Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 June 2015 (11+ years old) and is registered under CIN U85191UP2015PTC071548.
Alcuris Pharmaceuticals has 2 current directors:
- Sandeep Sahai - Managing Director
- Surpreet Sahai - Director
The latest financial statements of Alcuris Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Alcuris Pharmaceuticals is 09AANCA5528K1Z7, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Alcuris Pharmaceuticals is U85191UP2015PTC071548. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alcuris Pharmaceuticals has 2 court cases on record: 2 filed against it. 1 is pending.
Alcuris Pharmaceuticals was incorporated on 22 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Simran Singh ceased to be Director on 28 Feb 2020. Bal Govind Singh ceased to be Director on 17 Apr 2018. Sandeep Sahai ceased to be Additional Director on 17 Aug 2017. Alcuris Pharmaceuticals has 7 board changes on record in total.
The registered office of Alcuris Pharmaceuticals is at 647BI – 172A Jankipuram Garden, Lucknow, Uttar Pradesh, India – 226021.
Alcuris Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.